2025-08-01 2026-07-31 2026-07-31 false 03314230 Harwood House Limited 86900Other human health activities iso4217:GBP xbrli:pure 033142302025-08-01 033142302026-07-31 033142302025-08-01 2026-07-31 03314230bus:SmallEntities2025-08-01 2026-07-31 03314230bus:AuditExempt-NoAccountantsReport2025-08-01 2026-07-31 03314230bus:FullAccounts2025-08-01 2026-07-31 03314230core:WithinOneYear2026-07-31 03314230core:AfterOneYear2026-07-31 03314230core:WithinOneYear2025-08-01 2026-07-31 03314230core:AfterOneYear2025-08-01 2026-07-31 03314230core:CurrentFinancialInstruments2026-07-31 03314230core:Non-currentFinancialInstruments2026-07-31 03314230core:CurrentFinancialInstruments2025-08-01 2026-07-31 03314230core:Non-currentFinancialInstruments2025-08-01 2026-07-31 03314230core:LandBuildings2025-08-01 2026-07-31 03314230core:FurnitureFittings2025-08-01 2026-07-31 03314230core:OfficeEquipment2025-08-01 2026-07-31 03314230core:Vehicles2025-08-01 2026-07-31 03314230core:PlantMachinery2025-08-01 2026-07-31 03314230core:OtherPropertyPlantEquipment2025-08-01 2026-07-31 03314230core:LandBuildings2026-07-31 03314230core:PlantMachinery2026-07-31 03314230core:Vehicles2026-07-31 03314230core:FurnitureFittings2026-07-31 03314230core:OfficeEquipment2026-07-31 03314230core:OtherPropertyPlantEquipment2026-07-31 03314230core:Right-of-useAssets2025-08-01 2026-07-31 03314230core:Right-of-useAssets2026-07-31 03314230core:Goodwill2025-08-01 2026-07-31 03314230core:PatentsTrademarksLicencesConcessionsSimilar2025-08-01 2026-07-31 03314230core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-08-01 2026-07-31 03314230core:OtherResidualIntangibleAssets2025-08-01 2026-07-31 03314230core:Goodwill2026-07-31 03314230core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-07-31 03314230core:PatentsTrademarksLicencesConcessionsSimilar2026-07-31 03314230core:OtherResidualIntangibleAssets2026-07-31 03314230dpl:CostSales2025-08-01 2026-07-31 03314230dpl:AdministrativeExpenses2025-08-01 2026-07-31 03314230dpl:DistributionCosts2025-08-01 2026-07-3103314230core:ShareCapital2026-07-31 03314230core:SharePremium2026-07-31 03314230core:RevaluationReserve2026-07-31 03314230core:OtherReservesSubtotal2026-07-31 03314230core:ShareCapitalPreferenceShares2026-07-31 03314230core:CapitalRedemptionReserve2026-07-31 03314230core:OtherCapitalReserve2026-07-31 03314230core:RetainedEarningsAccumulatedLosses2026-07-3103314230core:ShareCapital2025-08-01 2026-07-31 03314230core:SharePremium2025-08-01 2026-07-31 03314230core:RevaluationReserve2025-08-01 2026-07-31 03314230core:OtherReservesSubtotal2025-08-01 2026-07-31 03314230core:RetainedEarningsAccumulatedLosses2025-08-01 2026-07-310331423012025-08-01 2026-07-31 0331423022025-08-01 2026-07-3103314230core:ShareCapital12025-08-01 2026-07-31 03314230core:ShareCapital22025-08-01 2026-07-3103314230core:SharePremium12025-08-01 2026-07-31 03314230core:SharePremium22025-08-01 2026-07-3103314230core:RevaluationReserve12025-08-01 2026-07-31 03314230core:RevaluationReserve22025-08-01 2026-07-3103314230core:RetainedEarningsAccumulatedLosses12025-08-01 2026-07-31 03314230core:RetainedEarningsAccumulatedLosses22025-08-01 2026-07-310331423012025-08-01 2026-07-3103314230core:Non-currentFinancialInstrumentscore:CostValuation2025-08-01 03314230core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-07-3103314230core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:CostValuation2026-07-3103314230core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-08-01 03314230core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-07-31 03314230core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-07-31 03314230core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-07-3103314230core:Non-currentFinancialInstruments2026-07-31 03314230core:Non-currentFinancialInstruments2025-07-31033142302024-08-01 033142302025-07-31 033142302024-08-01 2025-07-31 03314230core:WithinOneYear2025-07-31 03314230core:AfterOneYear2025-07-31 03314230core:CurrentFinancialInstruments2025-07-31 03314230core:Non-currentFinancialInstruments2025-07-31 03314230core:LandBuildings2025-07-31 03314230core:PlantMachinery2025-07-31 03314230core:Vehicles2025-07-31 03314230core:FurnitureFittings2025-07-31 03314230core:OfficeEquipment2025-07-31 03314230core:OtherPropertyPlantEquipment2025-07-31 03314230core:Right-of-useAssets2025-07-31 03314230core:Goodwill2025-07-31 03314230core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-07-31 03314230core:PatentsTrademarksLicencesConcessionsSimilar2025-07-31 03314230core:OtherResidualIntangibleAssets2025-07-31 03314230dpl:AdministrativeExpenses2024-08-01 2025-07-3103314230core:ShareCapital2025-07-31 03314230core:SharePremium2025-07-31 03314230core:RevaluationReserve2025-07-31 03314230core:OtherReservesSubtotal2025-07-31 03314230core:ShareCapitalPreferenceShares2025-07-31 03314230core:CapitalRedemptionReserve2025-07-31 03314230core:OtherCapitalReserve2025-07-31 03314230core:RetainedEarningsAccumulatedLosses2025-07-3103314230core:RetainedEarningsAccumulatedLosses2024-08-01 03314230core:ShareCapital2024-08-01 03314230core:SharePremium2024-08-01 03314230core:RevaluationReserve2024-08-01 03314230core:ShareCapital2024-08-01 2025-07-31 03314230core:SharePremium2024-08-01 2025-07-31 03314230core:RevaluationReserve2024-08-01 2025-07-31 03314230core:OtherReservesSubtotal2024-08-01 2025-07-31 03314230core:RetainedEarningsAccumulatedLosses2024-08-01 2025-07-310331423012024-08-01 2025-07-31 0331423022024-08-01 2025-07-3103314230core:ShareCapital12024-08-01 2025-07-31 03314230core:ShareCapital22024-08-01 2025-07-3103314230core:SharePremium12024-08-01 2025-07-31 03314230core:SharePremium22024-08-01 2025-07-3103314230core:RevaluationReserve12024-08-01 2025-07-31 03314230core:RevaluationReserve22024-08-01 2025-07-3103314230core:RetainedEarningsAccumulatedLosses12024-08-01 2025-07-31 03314230core:RetainedEarningsAccumulatedLosses22024-08-01 2025-07-3103314230bus:Director12025-08-01 2026-07-3103314230bus:Director22025-08-01 2026-07-3103314230bus:PrivateLimitedCompanyLtd2025-08-01 2026-07-31
Harwood House Limited
Unaudited Financial Statements
for the year ended 31 July 2026
Company registration number 03314230
(England and Wales)

Company Information

For the year ended 31 July 2026
Directors M C Fitch
M Forsyth

Company secretary Eagle's Head Limited

Registered office Harwood House, Spring Lane
Cookham Dean
Berkshire
SL6 6PW

Registered number 03314230

Accountant UHY Hacker Young Fitch
Suite 2.06
Custom House
Custom House Square
Belfast
Northern Ireland
BT1 3ET

Statement of Financial Position

As at 31 July 2026
Notes
2026
2025
£
£
£
£
Fixed assets
Tangible assets
4
352,966
344,215
352,966
344,215
Current assets
Debtors
5
214,799
135,777
Cash at bank and in hand
6
583,275
558,447
798,074
694,224
Creditors
Amounts falling due within one year
7
(472,261)
(452,847)
(472,261)
(452,847)
Net current assets (liabilities)
325,813
241,377
Total assets less current liabilities
678,779
585,592
Provisions for liabilities
8
(69,892)
(51,011)
Net assets (liabilities)
608,887
534,581
Capital and reserves
Called up share capital
2
2
Profit and loss account
608,885
534,579
Total equity
608,887
534,581

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 15 October 2026 and are signed on its behalf by:

M C Fitch
M C Fitch
Director

Company registration number 03314230

Notes to the Financial Statements

For the year ended 31 July 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

2.3. Turnover

Turnover represents amounts receivable from the provision of nursing care, residential care, accommodation and related services during the year, together with other operating income arising in the normal course of business. Turnover is measured at the fair value of the consideration received or receivable, net of discounts and rebates.


Revenue from nursing care, residential care and accommodation services is recognised as the services are provided to residents. Income is accrued over the period in which care and accommodation are provided, by reference to the occupancy and fee arrangements in place.


Income from local authorities, health trusts, residents and other funding bodies, including Funded Nursing Care contributions, is recognised in the period to which the services relate where entitlement has been established and receipt is probable.


Revenue from ancillary services and other income is recognised when the related goods have been supplied or services rendered, and when the amount of revenue can be measured reliably and it is probable that the economic benefits associated with the transaction will flow to the company.


Revenue is recognised only to the extent that it is probable that the economic benefits associated with the transaction will flow to the company and the amount of revenue can be measured reliably.

2.4. Employee benefits

Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

2.5. Pensions

Defined contribution pension plan

The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.

2.6. Operating leases

Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

2.7. Borrowing costs

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.


Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

2.8. Interest receivable

Interest income is recognised using the effective interest rate method.

2.9. Current taxation

Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income.


Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

2.10. Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

2.11. Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Rate
Method
%
Land and buildings
12.5
Straight-line
Plant and machinery
10
Straight-line
Motor vehicles
20
Straight-line
Fixtures and fittings
15
Straight-line

2.12. Financial instruments

Election and recognition

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.


Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.


Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.


If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.


Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

2.13. Trade and other debtors

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

2.14. Trade and other creditors

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

3. Employees

The average number of employees during the year was 31 (2025: 29).

4. Tangible fixed assets

Land and buildings
Plant and machinery
Motor vehicles
Fixtures and fittings
Total
£
£
£
£
£
Cost
At 1 August 2025
140,532
569,798
16,495
395,613
1,122,438
Additions
11,292
34,786
-
66,352
112,430
At 31 July 2026
151,824
604,584
16,495
461,965
1,234,868
Depreciation and impairment
At 1 August 2025
73,963
426,729
16,495
261,036
778,223
Charge for the period
12,194
57,676
-
33,809
103,679
At 31 July 2026
86,157
484,405
16,495
294,845
881,902
Net book value
At 31 July 2026
65,667
120,179
-
167,120
352,966
At 31 July 2025
66,569
143,069
-
134,577
344,215

5. Debtors

2026
2025
£
£
Trade debtors
173,312
80,656
Other debtors
6,490
25,793
Prepayments and accrued income
34,997
29,328
Total due within one year
214,799
135,777
Total due after one year
-
-
Total
214,799
135,777

6. Cash at bank and in hand

2026
2025
£
£
Cash at bank
583,275
558,447
Total
583,275
558,447

7. Creditors due within one year

2026
2025
£
£
Trade creditors
26,838
19,064
Amounts owed to associates, joint ventures and participating interests
21,918
13,145
Other creditors
345,675
347,703
Taxation and social security
46,629
30,989
Accruals and deferred income
31,201
41,946
Total
472,261
452,847

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

8. Provisions for liabilities

2026
2025
£
£
Deferred tax
69,892
51,011
Total
69,892
51,011

9. Deferred Tax

The deferred tax asset and provision consists of the following deferred tax liabilities/(assets):

2026
2025
£
£
Accelerated capital allowances
69,892
51,011
Net deferred tax liabilities/(assets)
69,892
51,011
Deferred tax liabilities
69,892
51,011
Net deferred tax liabilities/(assets)
69,892
51,011

The values of the deferred tax liabilities/(assets) at the balance sheet date have been calculated using the applicable rate when the asset is expected to be realised.

10. Pension commitments

The company operates a defined contribution pension scheme and the assets of the scheme are held separately from those of the company in an independently administered fund. At 31 July 2026 there were unpaid contributions of £3,133 (2025: £2,719) due to the fund, the balance of which is included within other creditors.

11. Operating lease commitments

At 31 July 2026 the company had future minimum lease payments under non-cancellable operating leases for each of the following periods:



2026

£

2025

£

Not later than 1 year

624,720

624,720

Later than 1 year and not later than 5 years

2,498,880

2,498,880

Later than 5 years

624,720

1,249,440

Total

3,748,320

4,373,040



12. Related party transactions

During the year the company entered into transactions with related parties in the normal course of business on normal commercial terms. These transactions comprised rental payments, management consultancy services and nursing care services. Outstanding balances at the year end were unsecured, interest free and repayable on demand.


Transactions with related parties during the year were as follows:


Entities with joint control or significant influence

Sales to related parties were £nil (2025: £6,057).

Purchases from related parties were £1,340,092 (2025: £1,219,642).

Amounts outstanding at the year end and included within creditors were £21,918 (2025: £13,145).


Entities controlled by key management personnel

Purchases from related parties were £20,707 (2025: £20,707).


Other related parties

Purchases from related parties were £105,458 (2025: £83,552).

Amounts outstanding at the year end and included within debtors were £508 (2025: £nil).


13. Controlling party

Harwood House Limited is a wholly owned subsidiary of Peterock Limited. Peterock Limited is registered in England at 222 Quadrangle Tower, Cambridge Square, London, W2 2PJ.


The ultimate controlling party is M C Fitch by virtue of his shareholdings in Peterock Limited